Nine-year Follow-up for a Study of Diffusion-weighted Magnetic Resonance Imaging in a Prospective Prostate Cancer Active Surveillance Cohort

European Urology

Volumn 69, Issue 6, 2016, Pages 1028-1033

  Henderson, Daniel R ^a,b   De Souza, Nandita M ^a,b   Thomas, Karen ^a   Riches, Sophie F ^a,b   Morgan, Veronica A ^a,b   Sohaib, Syed A ^a,b   Dearnaley, David P ^a,b   Parker, Christopher C ^a,b   Van As, Nicholas J ^a,b  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Active surveillance; Apparent diffusion coefficient; Diffusion weighting; Magnetic resonance imaging; Prostate cancer

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; APPARENT DIFFUSION COEFFICIENT; ARTICLE; CANCER STAGING; CLINICAL FEATURE; COHORT ANALYSIS; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; FOLLOW UP; GLEASON SCORE; HIGH RISK POPULATION; HISTOLOGY; HUMAN; HUMAN TISSUE; INTERMEDIATE RISK POPULATION; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PATIENT SELECTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE BIOPSY; PROSTATE CANCER; REPEAT PROCEDURE; TRANSRECTAL ULTRASONOGRAPHY; ADENOCARCINOMA; AREA UNDER THE CURVE; BIOPSY; BLOOD; BRACHYTHERAPY; CANCER GRADING; DIAGNOSTIC IMAGING; DISEASE EXACERBATION; PATHOLOGY; PROCEDURES; PROPORTIONAL HAZARDS MODEL; PROSTATE; PROSTATE TUMOR; PROSTATECTOMY; RECEIVER OPERATING CHARACTERISTIC; STATISTICAL MODEL; TIME FACTOR; WATCHFUL WAITING;

ADENOCARCINOMA; AGED; AREA UNDER CURVE; BIOPSY; BRACHYTHERAPY; DIFFUSION MAGNETIC RESONANCE IMAGING; DISEASE PROGRESSION; FOLLOW-UP STUDIES; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASM GRADING; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; ROC CURVE; TIME FACTORS; WATCHFUL WAITING;

EID: 84971642469     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2015.10.010     Document Type: Article

References (23)

1. European Association of Urology. Guidelines on prostate cancer. 2015. http://uroweb.org/guideline/prostate-cancer/
2. National Comprehensive Cancer Network. Clinical practice guidelines in oncology: prostate cancer. www.nccn.org/professionals/physician-gls/pdf/prostate.pdf
3. E.D. Selvadurai, M. Singhera, K. Thomas, and et al. Medium-term outcomes of active surveillance for localised prostate cancer Eur Urol 64 2013 981 987
4. L. Klotz, D. Vesprini, P. Sethukavalan, and et al. Long-term follow-up of a large active surveillance cohort of patients with prostate cancer J Clin Oncol 33 2015 272 277
5. J.J. Tosoian, B.J. Trock, P. Landis, and et al. Active surveillance program for prostate cancer: an update of the Johns Hopkins experience J Clin Oncol 29 2011 2185 2190
6. M.R. Cooperberg, J.E. Cowan, J.F. Hilton, and et al. Outcomes of active surveillance for men with intermediate-risk prostate cancer J Clin Oncol 29 2011 228 234
7. M. Bul, X. Zhu, R. Valdagni, and et al. Active surveillance for low-risk prostate cancer worldwide: the PRIAS study Eur Urol 63 2013 597 603
8. M.S. Soloway, C.T. Soloway, A. Eldefrawy, K. Acosta, B. Kava, and M. Manoharan Careful selection and close monitoring of low-risk prostate cancer patients on active surveillance minimizes the need for treatment Eur Urol 58 2010 831 835
9. R.C. van den Bergh, H.U. Ahmed, C.H. Bangma, M.R. Cooperberg, A. Villers, and C.C. Parker Novel tools to improve patient selection and monitoring on active surveillance for low-risk prostate cancer: a systematic review Eur Urol 65 2014 1023 1031
10. N. Van As, E. Charles-Edwards, A. Jackson, and et al. Correlation of diffusion-weighted MRI with whole mount radical prostatectomy specimens Br J Radiol 81 2008 456 462
11. C. Sato, S. Naganawa, T. Nakamura, and et al. Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate J Magn Reson Imaging 21 2005 258 262
12. V.A. Morgan, S. Kyriazi, S.E. Ashley, and N.M. DeSouza Evaluation of the potential of diffusion-weighted imaging in prostate cancer detection Acta Radiol 48 2007 695 703
13. N.J. van As, N.M. de Souza, S.F. Riches, and et al. A study of diffusion-weighted magnetic resonance imaging in men with untreated localised prostate cancer on active surveillance Eur Urol 56 2009 981 988
14. A.J. Simpkin, K. Tilling, R.M. Martin, and et al. Systematic review and meta-analysis of factors determining change to radical treatment in active surveillance for localized prostate cancer Eur Urol 67 2015 993 1005
15. R. Venkitaraman, A. Norman, R. Woode-Amissah, and et al. Predictors of histological disease progression in untreated, localized prostate cancer J Urol 178 2007 833 837
16. D.M. Somford, C.M. Hoeks, C.A. Hulsbergen-van de Kaa, and et al. Evaluation of diffusion-weighted MR imaging at inclusion in an active surveillance protocol for low-risk prostate cancer Invest Radiol 48 2013 152 157
17. V.A. Morgan, S.F. Riches, K. Thomas, and et al. Diffusion-weighted magnetic resonance imaging for monitoring prostate cancer progression in patients managed by active surveillance Br J Radiol 84 2011 31 37
18. I.G. Schoots, N. Petrides, F. Giganti, and et al. Magnetic resonance imaging in active surveillance of prostate cancer: a systematic review Eur Urol 67 2015 627 636
19. A. Walton Diaz, N.A. Shakir, A.K. George, and et al. Use of serial multiparametric magnetic resonance imaging in the management of patients with prostate cancer on active surveillance Urol Oncol 33 2015 202.e1-7
20. B. Turkbey, H. Mani, O. Aras, and et al. Prostate cancer: can multiparametric MR imaging help identify patients who are candidates for active surveillance? Radiology 268 2013 144 152
21. G. Giannarini, G. Petralia, and H.C. Thoeny Potential and limitations of diffusion-weighted magnetic resonance imaging in kidney, prostate, and bladder cancer including pelvic lymph node staging: a critical analysis of the literature Eur Urol 61 2012 326 340
22. O. Ukimura, J.A. Coleman, A. de la Taille, and et al. Contemporary role of systematic prostate biopsies: indications, techniques, and implications for patient care Eur Urol 63 2013 214 230
23. E. Lecornet, H.U. Ahmed, Y. Hu, and et al. The accuracy of different biopsy strategies for the detection of clinically important prostate cancer: a computer simulation J Urol 188 2012 974 980